Biohub, co-founded by Mark Zuckerberg and Priscilla Chan, has launched a groundbreaking open-source toolkit for protein science, featuring three AI models aimed at revolutionizing drug discovery. The suite includes ESMFold2 for protein structure prediction and design, ESMC as a protein language model, and the ESM Atlas, a comprehensive database of 6.8 billion proteins. These tools enable researchers to design proteins with therapeutic potential, validated through laboratory testing. Part of Biohub's $500 million Virtual Biology Initiative, this release democratizes access to advanced protein modeling, allowing smaller biotech startups to compete with established labs. The nonprofit's open-source approach underscores its commitment to scientific advancement over commercial gain, with no involvement in cryptocurrency or blockchain technologies.